Autoimmune diseases and autoimmunity post-bone marrow transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Autoimmunity

Background:

• Bone marrow transplantation (BMT) is explored for treating severe autoimmune diseases.
• BMT can paradoxically induce or exacerbate autoimmune conditions.
• Understanding post-transplant autoimmunity is crucial for patient outcomes.

Purpose of the Study:

• To investigate if chronic graft-versus-host disease (GVHD) is an autoimmune disease.
• To review autoimmune diseases reported after human BMT.
• To describe the autoimmune nature of the post-BMT state.

Main Methods:

• Literature review of autoimmune diseases following BMT.
• Analysis of clinical and pathogenic characteristics of chronic GVHD.
• Examination of post-BMT immune imbalances and contributing factors.

Main Results:

• Chronic GVHD shares features with autoimmune diseases like scleroderma and Sjogren's syndrome.
• Autoimmune diseases such as hypothyroidism, hyperthyroidism, myasthenia gravis, and immune cytopenias are reported post-BMT.
• Most post-BMT autoimmunity arises from immune dysregulation, not donor cell transfer.

Conclusions:

• Chronic GVHD exhibits autoimmune characteristics, potentially linked to thymic damage.
• Post-BMT autoimmunity can be severe, with unique presentations and prognoses.
• Genetic predisposition, infections (e.g., CMV), and donor-derived microchimerism influence post-BMT autoimmunity.